The phenotypic differentiation of locus ceruleus noradrenergic neurons mediated by brain-derived neurotrophic factor is enhanced by corticotropin releasing factor through the activation of a cAMP-dependent signaling pathway

Molecular Pharmacology

Volumn 70, Issue 1, 2006, Pages 30-40

  Traver, Sabine ^a,b   Marien, Marc ^c   Martin, Elodie ^a,b   Hirsch, Etienne C ^a,c   Michel, Patrick P ^a,c,d  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ASTRESSIN; BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR; CYCLIC AMP; DOPAMINE BETA MONOOXYGENASE; GUANINE NUCLEOTIDE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NEUROTROPHIN 4; NORADRENALIN; PHENYLETHANOLAMINE N METHYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CONTROLLED STUDY; EMBRYO; LOCUS CERULEUS; NONHUMAN; NORADRENERGIC NERVE; PHENOTYPE; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CELL DIFFERENTIATION; CELLS, CULTURED; CORTICOTROPIN-RELEASING HORMONE; CYCLIC AMP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME ACTIVATION; GENE EXPRESSION; LOCUS COERULEUS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NEURONS; NOREPINEPHRINE; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, WISTAR; RECEPTOR, TRKB; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TYROSINE 3-MONOOXYGENASE;

EID: 33745289118     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.106.022715     Document Type: Article

References (40)

1. Baigent SM and Lowry PJ (2000) mRNA expression profiles for corticotrophinreleasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues. J Mol Endocrinol 25:43-52.
2. Bale TL and Vale WW (2004) CRF and CRF receptors: role in stress responsivity and other behaviors. Annu Rev Pharmacol Toxicol 44:525-557.
3. Berridge CW and Waterhouse BD (2003) The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42:33-84.
4. Bezin L, Marcel D, Desgeorges S, Pujol JF, and Weissmann D (2000) Singular subsets of locus coeruleus neurons may recover tyrosine hydroxylase phenotype transiently expressed during development. Mol Brain Res 76:275-281.
5. Bos JL (2003) Epac: a new cAMP target and new avenues in cAMP research. Nat Rev Mol Cell Biol 4:733-738.
6. Carrasco GA and Van de Kar LD (2003) Neuroendocrine pharmacology of stress. Eur J Pharmacol 463:235-272.
7. Chen Y, Bender RA, Brunson KL, Pomper JK, Grigoriadis DE, Wurst W, and Baram TZ (2004) Modulation of dendritic differentiation by corticotropin- releasing factor in the developing hippocampus. Proc Natl Acad Sci USA 101:15782-15787.
8. Christensen AE, Selheim F, de Rooij J, Dremier S, Schwede F, Dao KK, Martinez A, Maenhaut C, Bos JL, Genieser HG, et al. (2003) cAMP analog mapping of Epac1 and cAMP kinase. Discriminating analogs demonstrate that Epac and cAMP kinase act synergistically to promote PC-12 cell neurite extension. J Biol Chem 278:35394-35402.
9. Cibelli G, Corsi P, Diana G, Vitiello F, and Thiel G (2001) Corticotropin-releasing factor triggers neurite outgrowth of a catecholaminergic immortalized neuron via cAMP and MAP kinase signalling pathways. Eur J Neurosci 13:1339-1348.
10. Ge Y, Belcher SM, and Light KE (2004) Alterations of cerebellar mRNA specific for BDNF, p75NTR and TrkB receptor isoforms occur within hours of ethanol administration to 4-day-old rat pups. Dev Brain Res 151:99-109.
11. Goodman LJ, Valverde J, Lim F, Geschwind MD, Federoff HJ, Geller AI, and Hefti F (1996) Regulated release and polarized localization of brain-derived neurotrophic factor in hippocampal neurons. Mol Cell Neurosci 7:222-238.
12. Ha BK, Bishop GA, King JS, and Burry RW (2000) Corticotropin releasing factor induces proliferation of cerebellar astrocytes. J Neurosci Res 62:789-798.
13. Hanson MG Jr, Shen S, Wiemelt AP, McMorris FA, and Barres BA (1998) Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J Neurosci 18:7361-7371.
14. Hirsch MR, Tiveron MC, Guillemot F, Brunet JF, and Goridis C (1998) Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development 125:599-608.
15. Holm PC, Rodriguez FJ, Kresse A, Canals JM, Silos-Santiago I, and Arenas E (2003) Crucial role of TrkB ligands in the survival and phenotypic differentiation of developing locus coeruleus noradrenergic neurons. Development 130:3535-3545.
16. Jedema HP and Grace AA (2004) Corticotropin-releasing hormone directly activates noradrenergic neurons of the locus ceruleus recorded in vitro. J Neurosci 24:9703-9713.
17. Kermer P, Klocker N, Labes M, and Bahr M (2000) Insulin-like growth factor-I protects axotomized rat retinal ganglion cells from secondary death via PI3-Kdependent Akt phosphorylation and inhibition of caspase-3 In vivo. J Neurosci 20:2-8.
18. Kim KS, Ishiguro H, Tinti C, Wagner J, and Joh TH (1994) The cAMP-dependent protein kinase regulates transcription of the dopamine beta-hydroxylase gene. J Neurosci 142:7200-7207.
19. Lim J, Yang C, Hong SJ, and Kim KS (2000) Regulation of tyrosine hydroxylase gene transcription by the cAMP-signaling pathway: involvement of multiple transcription factors. Mol Cell Biochem 212:51-60.
20. Marien MR, Colpaert FC, and Rosenquist AC (2004) Noradrenergic mechanisms in neurodegenerative diseases: a theory. Brain Res Rev 45:38-78.
21. Mayr B and Montminy M (2001) Transcriptional regulation by the phosphorylationdependent factor CREB. Nat Rev Mol Cell Biol 2:599-609.
22. Meier E, Hertz L, and Schousboe A (1991) Neurotransmitters as developmental signals. Neurochem Int 19:1-15.
23. Meyer-Franke A, Wilkinson GA, Kruttgen A, Hu M, Munro E, Hanson MG Jr, Reichardt LF, and Barres BA (1998) Depolarization and cAMP elevation rapidly recruit TrkB to the plasma membrane of CNS neurons. Neuron 21:681-693.
24. Michel PP, Ruberg M, and Agid Y (1997) Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J Neurochem 69:1499-1507.
25. Nagappan G and Lu B (2005) Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications. Trends Neurosci 28:464-471.
26. Patapoutian A and Reichardt LF (2001) Trk receptors: mediators of neurotrophin action. Curr Opin Neurobiol 11:272-280.
27. Prasad BM and Amara SG (2001) The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J Neurosci 21:7561-7567.
28. Radulovic M, Hippel C, and Spiess J (2003) Corticotropin-releasing factor (CRF) rapidly suppresses apoptosis by acting upstream of the activation of caspases. J Neurochem 84:1074-1085.
29. Rajagopal R, Chen ZY, Lee FS, and Chao MV (2004) Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes. J Neurosci 24:6650-6658.
30. Reiriz J, Holm PC, Alberch J, and Arenas E (2002) BMP-2 and cAMP elevation confer locus coeruleus neurons responsiveness to multiple neurotrophic factors. J Neurobiol 50:291-304.
31. Rusnak M and Gainer H (2005) Differential effects of forskolin on tyrosine hydroxylase gene transcription in identified brainstem catecholaminergic neuronal subtypes in organotypic culture. Eur J Neurosci 21:889-898.
32. Sakurada K, Ohshima-Sakurada M, Palmer TD, and Gage FH (1999) Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126:4017-4026.
33. Sauvage M and Steckler T (2001) Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the murine basal forebrain and brainstem nuclei: potential implication for arousal and attention. Neuroscience 1004:643-652.
34. Sklair-Tavron L and Segal M (1993) Neurotrophic effects of cAMP generating systems on central noradrenergic neurons. Brain Res 614:257-269.
35. Specht LA, Pickel VM, Joh TH, and Reis DJ (1981) Light-microscopic immunocytochemical localization of tyrosine hydroxylase in prenatal rat brain. I. Early ontogeny. J Comp Neurol 199:233-253.
36. Traver S, Salthun-Lassalle B, Marien M, Hirsch EC, Colpaert F, and Michel PP (2005) The neurotransmitter noradrenaline rescues septal cholinergic neurons in culture from degeneration caused by low-level oxidative stress. Mol Pharmacol 67:1882-1891.
37. 1/2) signaling pathway by cyclic AMP potentiates the neuroprotective effect of the neurotransmitter noradrenaline on dopaminergic neurons. Mol Pharmacol 62:1043-1052.
38. Unsworth BR, Hayman GT, Carroll A, and Lelkes PI (1999) Tissue-specific alternative mRNA splicing of phenylethanolamine N-methyltransferase (PNMT) during development by intron retention. Int J Dev Neurosci 17:45-55.
39. Van Bockstaele EJ, Colago EE, and Valentino RJ (1996) Corticotropin-releasing factor-containing axon terminals synapse onto catecholamine dendrites and may presynaptically modulate other afferents in the rostral pole of the nucleus locus coeruleus in the rat brain. J Comp Neurol 364:523-534.
40. Zarow C, Lyness SA, Mortimer JA, and Chui HC (2003) Neuronal loss is greater in the locus coeruleus than nucleus basalis and substantia nigra in Alzheimer and Parkinson diseases. Arch Neurol 60:337-341.